0001209191-23-006295.txt : 20230202
0001209191-23-006295.hdr.sgml : 20230202
20230202173644
ACCESSION NUMBER: 0001209191-23-006295
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230201
FILED AS OF DATE: 20230202
DATE AS OF CHANGE: 20230202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zojwalla Naseem
CENTRAL INDEX KEY: 0001905871
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 23582490
MAIL ADDRESS:
STREET 1: C/O OLEMA PHARMACEUTICALS, INC.
STREET 2: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001750284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300409740
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: (415) 651-3316
MAIL ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-01
0
0001750284
Olema Pharmaceuticals, Inc.
OLMA
0001905871
Zojwalla Naseem
C/O OLEMA PHARMACEUTICALS, INC.
512 2ND STREET, 4TH FLOOR
SAN FRANCISCO
CA
94107
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
4.87
2023-02-01
4
A
0
150000
0.00
A
2033-01-31
Common Stock
150000
150000
D
25% of the shares subject to the option vest on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
/s/ John B. Moriarty, Jr., Attorney-in-Fact
2023-02-02